Intravenous Hyoscine Butylbromide “Scopolamine” for the Treatment of Extrapyramidal Symptoms: A Case Report
Alanazi Saleh Farhan M. · Journal of Pharmaceutical Research International · 2023
Aim: Extrapyramidal symptoms (EPS) represent motor disturbances frequently induced by medications that impact the dopamine pathways. Although not traditionally employed for addressing EPS, there is potential in using hyoscine butylbromide, an anticholinergic antispasmodic, owing...
Open access
Research Article
10.9734/jpri/2023/v35i277445